Skip to content
★ Sign in to follow
NL

New Leaf Ventures I, L.P.

Shareholder
Related company / holding
Paratek Pharmaceuticals, Inc.Relypsa IncConcert Pharmaceuticals, Inc.
Total declarations
14
Companies
3
▲ Purchases (1 ops.)
€1.5M
▼ Sales (4 ops.)
€1.5M

Latest filing published 21 Feb 2014 for Concert Pharmaceuticals, INC..

Insider track record

Disclosed buys
1
Disclosed sells
4
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

New Leaf Ventures I, L.P.: trading record in brief

New Leaf Ventures I, L.P. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Relypsa Inc, Paratek Pharmaceuticals, Inc. and Concert Pharmaceuticals, Inc. Between 13 July 2011 and 19 February 2014, the trades on record add up to 14 filings.

Market trades split into 1 purchase (€1.5M) and 4 sales (€1.5M). Taken together, the sales exceed the purchases by €3,679. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise.

The latest filing, published on 21 February 2014, reports a transaction in Concert Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,737 days ago, on 20 November 2013. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to New Leaf Ventures I, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total

14 of 14 declarations